Remarkably, we identified KEAP1 mutations in all thyroid cancer histologies, ranging from well-differentiated forms (PTC, FTC) to PDTC and ATC, with no subtype-specific mutational pattern. This evidence concerns the gene KEAP1 and thyroid gland carcinoma.